Genetics, Environment, and Diabetes-Related End-Stage Renal Disease in the Canary Islands

González, Ana M.; Maceira, B.; Pérez, Estefanía; Cabrera, Vicente M.; López, Alfonso J.; Larruga, J. M.

doi:10.1089/gtmb.2011.0207

Cited by 13 publications

(6 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another important finding that affects dialysis delivery is the nephrology staff shortage, as the number of renal experts, including nurses, nephrologists and technicians, was surprisingly too small and overwhelmed by the increasing daily number of patients with ESKD in the dialysis units (Tadesse et al, 2021 ). These results corroborate the findings of a great deal of previous work in Latin America, where the number of nephrologists varies from 1.7 per million of the population in Honduras to 53.9 per million of the population in Uruguay (Gonzalez et al, 2012 ). Similarly, in Asia, the range is from 0.2 per million of the population in Burma and Indonesia to 5.0 per million in Thailand (Jha et al, 2013 ).…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Japiong,

Landy,

Fox

et al. 2023

Nursing Open

View full text Add to dashboard Cite

AimsThis scoping review examined the factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa.DesignScoping review.MethodsThe scoping review is conducted following the Joanna Briggs Institute methodology for scoping reviews and modelled by Preferred Reporting Items for Systematic Reviews and Meta‐analyses extension for scoping review.ResultsA descriptive content analysis of 30 included articles revealed three main findings affecting access and use of dialysis: Health system–related factors, health provider–related factors and patient factors.Patient or Public ContributionEquity in renal replacement therapy access and use will require concerted advocacy for good public policy, healthcare delivery, workforce capacity and education.

show abstract

Section: Discussionsupporting

confidence: 91%

“…where the number of nephrologists varies from 1.7 per million of the population in Honduras to 53.9 per million of the population in Uruguay (Gonzalez et al, 2012). Similarly, in Asia, the range is from 0.2 per million of the population in Burma and Indonesia to 5.0 per million in Thailand (Jha et al, 2013).…”

Section: Provider-related Factorsmentioning

confidence: 99%

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Japiong,

Landy,

Fox

et al. 2023

Nursing Open

View full text Add to dashboard Cite

show abstract

“…A haplotype group is a collection of alleles that are transmitted together and may relate to different health characteristics or disease risk profiles. At present, haplotype groups are being assessed for diabetes [ 25 ], obesity [ 26 ], hypertension [ 27 ], and immune disease (looking comprehensively at the genes in the major histocompatibility complex (MHC)) [ 28 ].…”

Section: The Realization Of Health 2050: Preventive Medicinementioning

confidence: 99%

Health 2050: The Realization of Personalized Medicine through Crowdsourcing, the Quantified Self, and the Participatory Biocitizen

Swan

2012

JPM

342

215

View full text Add to dashboard Cite

The concepts of health and health care are moving towards the notion of personalized preventive health maintenance and away from an exclusive focus on the cure of disease. This is against the backdrop of contemporary public health challenges that include increasing costs, worsening outcomes, ‘diabesity’ epidemics, and anticipated physician shortages. Personalized preventive medicine could be critical to solving public health challenges at their causal root. This paper sets forth a vision and plan for the realization of preventive medicine by 2050 and examines efforts already underway such as participatory health initiatives, the era of big health data, and qualitative shifts in mindset.

show abstract

“…Structural cardiac changes such as LVH and LVF through modulation of fetal genes and suppression of adult genes requires gene reprogramming that is potentially transmissible [ 21 , 120 - 122 ]. For mother’s rheumatic heart diseases and predispositions in developing peripartum cardiomyopathies, place risks on the child and mother and for future pregnancies [ 123 - 125 ]. For children programming starts early with higher incidences of low birth weight, preterm delivery, infection exposure and higher risk cardiovascular pregnancies [ 88 ].…”

Section: Genetics In Indigenous Australiansmentioning

confidence: 99%

Contextualizing Genetics for Regional Heart Failure Care

Iyngkaran

Thomas²,

Johnson³

et al. 2016

CCR

View full text Add to dashboard Cite

Congestive heart failure (CHF) is a chronic and often devastating cardiovascular disorder with no cure. There has been much advancement in the last two decades that has seen improvements in morbidity and mortality. Clinicians have also noted variations in the responses to therapies. More detailed observations also point to clusters of diseases, phenotypic groupings, unusual severity and the rates at which CHF occurs. Medical genetics is playing an increasingly important role in answering some of these observations. This developing field in many respects provides more information than is currently clinically applicable. This includes making sense of the established single gene mutations or uncommon private mutations. In this thematic series which discusses the many factors that could be relevant for CHF care, once established treatments are available in the communities; this section addresses a contextual role for medical genetics.

show abstract

Genetics, Environment, and Diabetes-Related End-Stage Renal Disease in the Canary Islands

Cited by 13 publications

References 31 publications

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Health 2050: The Realization of Personalized Medicine through Crowdsourcing, the Quantified Self, and the Participatory Biocitizen

Contextualizing Genetics for Regional Heart Failure Care

Contact Info

Product

Resources

About